top of page
Buscar

New Paper in ChemMedChem!

medorglab
7 de set.
1 min de leitura

Atualizado: 10 de set.

We are pleased to announce the recent publication in ChemMedChem!!


This study expands the potential of the small molecule RVJB59 as a targeted therapy for breast cancers carrying the clinically relevant R280K and R273H mutants p53. Combining biophysical, mass spectrometry, and computational approaches, we demonstrate that RVJB59 stabilizes mutant p53 and covalently binds to Cys141, highlighting a promising strategy to target cancer with these relevant mutations.



 
 
 

Posts recentes

Ver tudo
Welcome to our new students!

We are delighted to welcome the newest members of our research group - Iara Silva, Sofia Régio, David Pires, Teresa Moura and Ana Castro! This year, we are joined by a group of students who bring fres

 
 
 

Comentários


Copyright © 2026 | by Medicinal Organic Chemistry Group

bottom of page